Amr Ghaleb et al. find that, in an ErbB2 mouse model, irradiation of premalignant mammary lesions enhances tumorigenesis in tumours that are heterozygous for p53 containing a p53 R172H mutation. Here, ERBB2 is linked to neoplasm.